Q1 2025 · 13F-HR
Aquilo Capital Management, LLCholdings as filed
Filed 2025-05-15 · accession 0001591986-25-000004
$55.8M
Reported value
13
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 031162100 | AMGN | AMGEN INC | $18.7M | 33.5% | 60,000 | CALL | NONE |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES CORP | $7.4M | 13.3% | 83,926 | Common | SOLE |
| 04280A100 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $7.0M | 12.6% | 550,130 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $4.0M | 7.08% | 81,692 | Common | SOLE |
| 501575104 | KYMR | KYMERA THERAPEUTICS INC | $3.8M | 6.80% | 138,521 | Common | SOLE |
| 74019P207 | DTIL | PRECISION BIOSCIENCES INC | $3.5M | 6.21% | 726,149 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $2.5M | 4.54% | 360,766 | Common | SOLE |
| 75901B107 | RGNX | REGENXBIO INC | $1.9M | 3.48% | 271,302 | Common | SOLE |
| 007002108 | TORCEUR | ADICET BIO INC | $1.9M | 3.32% | 2,456,194 | Common | SOLE |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $1.5M | 2.61% | 171,695 | Common | SOLE |
| N44445109 | IMTX | IMMATICS N.V | $1.4M | 2.47% | 304,902 | Common | SOLE |
| 760273102 | RPTX | REPARE THERAPEUTICS INC | $1.3M | 2.29% | 1,293,715 | Common | SOLE |
| 98985Y108 | ZYME | ZYMEWORKS INC | $1.0M | 1.80% | 84,482 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.